Uterine sarcoma Part I-Uterine leiomyosarcoma: The Topic Advisory Group systematic review

• 主要な著者: Kuo-Chang Wen (著者), Huann-Cheng Horng (著者), Peng-Hui Wang (著者), Yi-Jen Chen (著者), Ming-Shyen Yen (著者), Heung-Tat Ng (著者), Yen-Hou Chang (著者), Yi Chang (著者), Hsiang-Tai Chao (著者), Kuan-Chong Chao (著者), Chi-Mu Chuang (著者), Chi-Hong Ho (著者), Chen-Yu Huang (著者), Zhi-Chen Hung (著者), Ling-Yu Jiang (著者), Hei-Yu Lau (著者), Hsin-Yang Li (著者), Chi-Yao Lin (著者), Chia-Hao Liu (著者), Pi-Lin Sun (著者), Nae-Fang Twu (著者), Hua-Hsi Wu (著者), Hann-Chin Yu (著者), Fong-Yuan Ju (著者), Chih-Ping Tsai (著者), Wen-Hsun Chang (著者), Yen-Mei Hsu (著者), Na-Rong Lee (著者), Chih-Yao Chen (著者), Ting-Chen Chang (著者), Wen-Chun Chang (著者), Chii-Hou Chen (著者), Ruey-Jian Chen (著者), Song-Nan Chow (著者), Yih-Ron Lien (著者), Bor-Ching Sheu (著者), Pao-Ling Torng (著者), Men-Luh Yen (著者), Wen-Ling Lee (著者), Kuan-Chin Wang (著者), Chih-Long Chang (著者), Chih-Ping Chen (著者), Jen-Ruei Chen (著者), Tze-Chien Chen (著者), Jian-Pei Huang (著者), Ming-Chao Huang (著者), Yeou-Lih Wang (著者), Cheng-Chang Chang (著者), Jah-Yao Liu (著者), Her-Young Su (著者), Yu-Chi Wang (著者), Mu-Hsien Yu (著者), Lee-Wen Huang (著者), Kok-Min Seow (著者), Tsung-Hsuan Lai (著者), Fa-Kung Lee (著者), Ching-Hui Chen (著者), Ben-Shian Huang (著者), Sheng-Mou Hsiao (著者), Hsu-Dong Sun (著者), Wen-Yih Wu (著者), Sen-Wen Teng (著者), Kuo-Hu Chen (著者), Jeng-Hsiu Hung (著者), Hung-Cheng Lai (著者), Chiou-Chung Yuan (著者), Ching-Hung Hsieh (著者), Chin-Jung Wang (著者), Shing-Jyh Chang (著者), Man-Jung Hung (著者), Shih-Tien Hsu (著者), Yu-Min Ke (著者), Chien-Hsing Lu (著者), Lou Sun (著者), Wei-Chun Chang (著者), Yao-Ching Hung (著者), Wu-Chou Lin (著者), Po-Hui Wang (著者), Tze-Ho Chen (著者), Yiu-Tai Li (著者), Meng-Hsing Wu (著者), Kuo-Feng Huang (著者), Hung-Chun Fu (著者), San-Nung Chen (著者), An-Jen Chiang (著者), Ju-Yueh Li (著者), Li-Te Lin (著者), Hsiao-Wen Tsai (著者), Kuan-Hao Tsui (著者)
• フォーマット: 図書
• 出版事項: Elsevier, 2016-08-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Uterine sarcomas account for 3-7% of all uterine cancers. Because of their rarity, unknown etiology, and highly divergent genetic aberration, there is a lack of consensus on risk factors for occurrence and predictive poor outcomes as well as optimal therapeutic choices. Tumor types according to the...